Hannah R. Sullivan and Scott J. Schweikart, JD, MBE
Legal questions regarding clinicians’ and technology manufacturers’ liability arise when algorithmic recommendations generated by the technology are hard to understand.
AMA J Ethics. 2019; 21(2):E160-166. doi:
10.1001/amajethics.2019.160.
Haley Moulton, Benjamin Moulton, JD, MPH, Tim Lahey, MD, MMSc, and Glyn Elwyn, MD, PhD, MSc
Shared decision making in research informed consent conversations is complex due to diverse and potentially divergent interests of investigators and patient-subjects.
AMA J Ethics. 2020; 22(5):E365-371. doi:
10.1001/amajethics.2020.365.
William F. Parker, MD, MS and Marshall H. Chin, MD, MPH
Given organ scarcity, transplantation programs state that patient promises of compliance cannot be taken at face value, excluding candidates who are deemed untrustworthy.
AMA J Ethics. 2020; 22(5):E408-415. doi:
10.1001/amajethics.2020.408.
John is one patient-sitter whose cancer and portraiture experiences illuminate what it means to witness, to express regard for another’s difficult health and health care experiences.
AMA J Ethics. 2020; 22(6):E470-475. doi:
10.1001/amajethics.2020.470.